44 related articles for article (PubMed ID: 12115198)
1. Lyme disease vaccine.
Halperin SA
Can J Infect Dis; 2000 May; 11(3):132-4. PubMed ID: 18159278
[No Abstract] [Full Text] [Related]
2. Progress and controversy surrounding vaccines against Lyme disease.
Hanson MS; Edelman R
Expert Rev Vaccines; 2003 Oct; 2(5):683-703. PubMed ID: 14711329
[TBL] [Abstract][Full Text] [Related]
3. Estimating the population health burden of Lyme disease in Ontario, Canada: a microsimulation modelling approach.
Mac S; Evans GA; Patel SN; Pullenayegum EM; Sander B
CMAJ Open; 2021; 9(4):E1005-E1012. PubMed ID: 34785530
[TBL] [Abstract][Full Text] [Related]
4. Comparative Cost and Effectiveness of a New Algorithm for Early Lyme Disease Diagnosis: Evaluation in US, Germany, and Italy.
Pradelli L; Pinciroli M; Houshmand H; Grassi B; Bonelli F; Calleri M; Ruscio M
Clinicoecon Outcomes Res; 2021; 13():437-451. PubMed ID: 34079307
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic outcomes evaluated in Lyme disease: a systematic review.
Mattingly TJ; Shere-Wolfe K
Parasit Vectors; 2020 Jul; 13(1):341. PubMed ID: 32646476
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
Mac S; da Silva SR; Sander B
PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
[TBL] [Abstract][Full Text] [Related]
7. Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study.
Lantos PM; Brinkerhoff RJ; Wormser GP; Clemen R
Vector Borne Zoonotic Dis; 2013 Dec; 13(12):877-83. PubMed ID: 24107201
[TBL] [Abstract][Full Text] [Related]
8. Pricing of new vaccines.
Lee BY; McGlone SM
Hum Vaccin; 2010 Aug; 6(8):619-26. PubMed ID: 20861678
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Lyme borreliosis.
Girschick HJ; Morbach H; Tappe D
Arthritis Res Ther; 2009; 11(6):258. PubMed ID: 20067594
[TBL] [Abstract][Full Text] [Related]
10. Lyme disease.
Coyle PK
Curr Neurol Neurosci Rep; 2002 Nov; 2(6):479-87. PubMed ID: 12359100
[TBL] [Abstract][Full Text] [Related]
11. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of vaccination against Lyme disease.
Shadick NA; Liang MH; Phillips CB; Fossel K; Kuntz KM
Arch Intern Med; 2001 Feb; 161(4):554-61. PubMed ID: 11252114
[TBL] [Abstract][Full Text] [Related]
13. Vaccination for Lyme disease: cost-effectiveness versus cost and value.
Sigal LH
Arthritis Rheum; 2002 Jun; 46(6):1439-42. PubMed ID: 12115172
[No Abstract] [Full Text] [Related]
14. American Academy of Pediatrics. Committee on Infecious Diseases. Prevention of Lyme disease.
Pediatrics; 2000 Jan; 105(1 Pt 1):142-7. PubMed ID: 10617720
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the Lyme disease vaccine.
Hsia EC; Chung JB; Schwartz JS; Albert DA
Arthritis Rheum; 2002 Jun; 46(6):1651-60. PubMed ID: 12115198
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
